A Study of GC101 TIL in Advanced Breast Cancer (10hospital)

Clinical trial NCT05142475 · RECRUITING

Trial details

NCT number: NCT05142475
Sponsor: Shanghai Juncell Therapeutics
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Breast Cancer Treatment Side Effects Advanced Breast Cancer Effects of Immunotherapy

Start date: 2021-11-19
Primary completion: 2026-12-20
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.